SCHEMBL31061055

SCHEMBL31061055

COc1cc2ncnc(Oc3cccc(Cl)c3)c2cc1OC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 5/20 1.00
▸ LCK P06239 3/20 1.00
▸ KDR P35968 8/20 0.73
▸ RET P07949 1/20 0.73
▸ KIF5B P33176 1/20 0.73
▸ BRAF P15056 5/20 0.65
▸ RAF1 P04049 4/20 0.61
▸ CSF1R P07333 1/20 0.61
▸ PDGFRB P09619 1/20 0.61
▸ FLT4 P35916 1/20 0.61
▸ FLT3 P36888 1/20 0.61
▸ KDM4E B2RXH2 1/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ GMNN O75496 1/20 0.57
▸ ALDH1A1 P00352 1/20 0.57
▸ ABL1 P00519 1/20 0.57
▸ LMNA P02545 1/20 0.57
▸ TP53 P04637 1/20 0.57
▸ CYP1A2 P05177 1/20 0.57
▸ GLA P06280 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6182199 1.00 EGFR (1.00) EGFRLCKKDRRETKIF5B
SCHEMBL20229657 0.85 KDR (0.74) EGFRLCKKDRRETKIF5B
SCHEMBL13680204 0.85 KDR (0.73) EGFRLCKKDRRETKIF5B
SCHEMBL15463614 0.84 KDR (0.73) EGFRLCKKDRRETKIF5B
SCHEMBL1012448 0.84 KDR (0.73) EGFRLCKKDRRETKIF5B
SCHEMBL31060791 0.84 KDR (1.00) EGFRLCKKDRRETKIF5B
SCHEMBL6181628 0.84 EGFR (0.72) EGFRLCKKDRRETKIF5B
SCHEMBL15463602 0.83 EGFR (0.71) EGFRLCKKDRRETKIF5B
SCHEMBL18158553 0.82 KDR (0.70) EGFRLCKKDRRETKIF5B
SCHEMBL23457663 0.82 LCK (0.74) EGFRLCKKDRRETKIF5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 — — EP disclosed
WO-2024168301-A2 PERSONALIZED CRISPR PROFILING FOR CANCER FUNCTION ONCOLOGY, INC. (US) 2024-08-15 — — WO disclosed
Send feedback